Human cardiac fibroblast extracellular matrix remodeling: Dual effects of tissue inhibitor of metalloproteinase-2

Cardiovascular Pathology

Volumn 23, Issue 6, 2014, Pages 335-343

  Ngu, Janet M C ^a   Teng, Guoqi ^a   Meijndert, Hans Christopher ^a   Mewhort, Holly E ^a   Turnbull, Jeannine D ^a   Stetler Stevenson, William G ^b   Fedak, Paul W M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cardiac fibroblasts; Extracellular matrix; Human cells; Remodelling; TIMP 2

Indexed keywords

ILOMASTAT; MATRIX METALLOPROTEINASE; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; COLLAGEN; TIMP2 PROTEIN, HUMAN;

ARTICLE; CARDIAC FIBROBLAST; CELL ACTIVATION; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; MYOFIBROBLAST; PRIORITY JOURNAL; ZYMOGRAPHY; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; HEART ATRIUM APPENDAGE; HEART ATRIUM REMODELING; HEART MUSCLE; METABOLISM; PHYSIOLOGY; TUMOR MICROENVIRONMENT;

ATRIAL APPENDAGE; ATRIAL REMODELING; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; COLLAGEN; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASES; MODELS, CARDIOVASCULAR; MYOCARDIUM; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84923035106     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2014.06.003     Document Type: Article

References (34)

1. RK Nuttall, CL Sampieri, CJ Pennington, SE Gill, GA Schultz, and DR Edwards Expression analysis of the entire MMP and TIMP gene families during mouse tissue development FEBS Lett 563 2004 129 134
2. DE Gomez, DF Alonso, H Yoshiji, and UP Thorgeirsson Tissue inhibitors of metalloproteinases: structure, regulation and biological functions Eur J Cell Biol 74 1997 111 122
3. SJ Lee, PS Tsang, TM Diaz, BY Wei, and WG Stetler-Stevenson TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cells Lab Invest 90 2010 374 382
4. D Seo, S Kim, S Eom, and H Yoon TIMP-2 disrupts FGF-2-induced downstream signaling pathways Microvasc Res 76 2008 145 151
5. Z Wang, R Juttermann, and PD Soloway TIMP-2 is required for efficient activation of proMMP-2 in vivo J Biol Chem 275 2000 26411 26415
6. CA Souders, SL Bowers, and TA Baudino Cardiac fibroblast: the renaissance cell Circ Res 105 2009 1164 1176
7. EM Wilson, SL Moainie, JM Baskin, AS Lowry, AM Deschamps, R Mukherjee, TS Guy, MG St John-Sutton, JH Gorman, LH Edmunds, RC Gorman, and FG Spinale Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling Circulation 107 2003 2857 2863
8. V Kandalam, R Basu, T Abraham, X Wang, PD Soloway, DM Jaworski, GY Oudit, and Z Kassiri TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation Circ Res 106 2010 796 808
9. R Ramani, K Nilles, G Gibson, B Burkhead, M Mathier, D McNamara, and CF McTiernan Tissue inhibitor of metalloproteinase-2 gene delivery ameliorates postinfarction cardiac remodeling Clin Transl Sci 4 2011 24 31
10. PWM Fedak, L Bai, J Turnbull, J Ngu, K Narine, and HJ Duff Cell therapy limits myofibroblast differentiation and structural cardiac remodeling: basic fibroblast growth factor-mediated paracrine mechanism Circ Heart Fail 5 2012 349 356
11. JD Lovelock, AH Baker, F Gao, JF Dong, AL Bergeron, W McPheat, N Sivasubramanian, and DL Mann Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts Am J Physiol Heart Circ Physiol 288 2005 H461 H468
12. PT Wingfield, JK Sax, SJ Stahl, J Kaufman, I Palmer, V Chung, ML Corcoran, DE Kleiner, and WG Stetler-Stevenson Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli J Biol Chem 274 1999 21362 21368
13. D Harjanto, JS Maffei, and MH Zaman Quantitative analysis of the effect of cancer invasiveness and collagen concentration on 3D matrix remodeling PLoS One 6 2011 e24891
14. A Chhabra, A Jaiswal, U Malhotra, S Kohli, and V Rani Cell in situ zymography: an in vitro cytotechnology for localization of enzyme activity in cell culture In Vitro Cell Dev Biol Anim 48 2012 463 466
15. MC Cha, and PP Purslow Matrix metalloproteinases are less essential for the in-situ gelatinolytic activity in heart muscle than in skeletal muscle Comp Biochem Physiol A Mol Integr Physiol 156 2010 518 522
16. E Huet, B Vallée, D Szul, F Verrecchia, S Mourah, JV Jester, T Hoang-Xuan, S Menashi, and EE Gabison Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling FASEB J 22 2008 1144 1154
17. P Lijnen, V Petrov, and R Fagard Transforming growth factor-beta 1-mediated collagen gel contraction by cardiac fibroblasts J Renin Angiotensin Aldosterone Syst 4 2003 113 118
18. G Gabbiani, GB Ryan, and G Majne Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction Experientia 27 1971 549 550
19. C Guidry, and F Grinnell Studies on the mechanism of hydrated collagen gel reorganization by human skin fibroblasts J Cell Sci 79 1985 67 81
20. A Margulis, KH Nocka, NL Wood, SF Wolf, SJ Goldman, and MT Kasaian MMP dependence of fibroblast contraction and collagen production induced by human mast cell activation in a three-dimensional collagen lattice Am J Physiol Lung Cell Mol Physiol 296 2009 L236 L247
21. MJ Toriseva, R Ala-aho, J Karvinen, AH Baker, VS Marjomaki, J Heino, and VM Kahari Collagenase-3 (MMP-13) enhances remodeling of three-dimensional collagen and promotes survival of human skin fibroblasts J Invest Dermatol 127 2007 49 59
22. S Rohr Cardiac fibroblasts in cell culture systems: myofibroblasts all along? J Cardiovasc Pharmacol 57 2011 389 399
23. J Santiago, AL Dangerfield, SG Rattan, KL Bathe, RH Cunnington, JE Raizman, KM Bedosky, DH Freed, E Kardami, and IMC Dixon Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts Dev Dyn 239 2010 1573 1584
24. J Fringer, and F Grinnell Fibroblast quiescence in floating or released collagen matrices: contribution of the ERK signaling pathway and actin cytoskeletal organization J Biol Chem 276 2001 31047 31052
25. MB Larsen, RW Stephens, N Brunner, HJ Nielsen, LH Engelholm, IJ Christensen, WG Stetler-Stevenson, and G Hoyer-Hansen Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients Scand J Immunol 61 2005 449 460
26. MM Bildt, M Bloemen, AM Kuijpers-Jagtman, and JW Von den Hoff Matrix metalloproteinase inhibitors reduce collagen gel contraction and alpha-smooth muscle actin expression by periodontal ligament cells J Periodontal Res 44 2009 266 274
27. FG Spinale Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function Physiol Rev 87 2007 1285 1342
28. GL Brower, JD Gardner, MF Forman, DB Murray, T Voloshenyuk, SP Levick, and JS Janicki The relationship between myocardial extracellular matrix remodeling and ventricular function Eur J Cardiothorac Surg 30 2006 604 610
29. MA Karsdal, L Larsen, MT Engsig, H Lou, M Ferreras, A Lochter, J Delaissé, and NT Foged Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis J Biol Chem 277 2002 44061 44067
30. Q Yu, and I Stamenkovic Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis Genes Dev 14 2000 163 176
31. DW Seo, H Li, CK Qu, J Oh, YS Kim, T Diaz, B Wei, JW Han, and WG Stetler-Stevenson Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells J Biol Chem 281 2006 3711 3721
32. GM Tierney, NR Griffin, RC Stuart, H Kasem, KP Lynch, JT Lury, PD Brown, AW Millar, RJ Steele, and SL Parsons A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer Eur J Cancer 35 1999 563 568
33. MP Hudson, PW Armstrong, W Ruzyllo, J Brum, L Cusmano, P Krzeski, R Lyon, M Quinones, P Theroux, D Sydlowski, HE Kim, MJ Garcia, WA Jaber, and WD Weaver Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial J Am Coll Cardiol 48 2006 15 20
34. CL Gibbs, and DS Loiselle Cardiac basal metabolism Jpn J Physiol 51 2001 399 426